Activation ofhuman T lymphocytes can be initiated through two major pathways : one of these is antigen specific, whereas the other is antigen independent. Antigenspecific activation is mediated via the TCR (CD3Ti) complex, which transducer signals after interacting with processed antigen in conjunction with MHC gene products. Similar activation can be induced experimentally by crosslinking the CD3 Ti complex with antibodies directed against individual TCR subunit proteins (1) (2) (3) . An alternative antigen-independent pathway has been described based upon the in vitro observation that perturbation of the CD2 (T11) molecule with a combination of antibodies defining two different epitopes (anti-T112 and anti T113) is able to induce cell activation and proliferation (4) . The physiological counterpart of anti-T112+ 3 is still unknown; however, the cell adhesion structure LFA-3 appears to be one natural ligand for CD2 (5) that could provide part of the activation stimulus mediated by anti-T11 antibodies in vitro (6, 7) .
Interaction of membrane receptors with appropriate mitogenic stimuli for the antigen-specific and alternative pathways results in a virtually identical series ofevents involving phosphatidyl inositol turnover with subsequent production of 1, 4, 5 inositol trisphosphate (IP3)' and diacylglycerol (8, 9) . IP3 is directly responsible for a rise in intracellular free calcium ([Ca2+ ] i) as a consequence of mobilization from intracellular stores (10) and/or transmembrane calcium flux (11, 12) , while diacylglycerol is an endogenous activator of protein kinase C (13) . Previous studies have shown that both a rise in intracellular free calcium [Ca2+ ]i as well as phosphorylation events mediated through protein kinase C activation are necessary for IL-2 gene induction (14) .
Given the similarities in early signal transduction via CD3Ti and CD2 structures and their coexpression on the surface ofmature T lymphocytes, the interdependence ofthe two pathways has been suggested, but remains to be fully investigated . Herein, we describe the production and characterization of CD2-CD3Ti+ variants derived from the Jurkat CD2' CD3 Ti+ human T cell line. These mutants express normal levels of CD3 Ti-a/p molecules but lack any detectable surface CD2 molecules as judged by immunoprecipitation experiments and Scatchard analysis. Nevertheless, functional studies clearly establish that these cells can be activated via their CD3Ti receptor, retaining the capacity to mediate all the aforementioned events associated with the transduction of activation signals . Assuming that Jurkat cells are representative of their normal cycling cellular counterparts, we conclude that CD2 is not required to activate mature T lymphocytes through their TCRs.
Materials and Methods
Cells. Variants ofthe Jurkat T cell line (cloneJ77-6.8, kindly provided by Dr. K. Smith, Dartmouth Medical School, Hanover, NH) lacking surface expression of the CD2 molecule were derived by mutagenesis, immunoselection, and all sorting, as previously described (15) . Briefly, 107 cells were irradiated (300 rad) in a y cell irradiator (model 1,000; Atomic Energy of Canada Ltd ., Ontario, Canada) using a 117 cesium source. After 5 d in culture, cells were incubated 1 h at room temp with a mixture of antiTll 1 (clone 3Pt2H9) and antiT112 (lold241C) ascites used at a 1 :100 final dilution . Rabbit sera (Pel-Freeze Biologicals, Rogers, AR) at a dilution of 1 :3 was added as a source of complement for 1 h at 37°C. The procedure was repeated four times and viable cells were isolated by centrifugation over a Ficoll-Hypaque density gradient (Pharmacia Fine Chemicals, Piscataway, NJ). CD3' Ti' CD2-cells were sorted using an Epic V cell sorter (Coulter Electronics Inc., Hialeah, FL) and cloned at 1 cell/well . 19 CD3'Ti'CD2 -colonies were obtained, and three ofthese clones, termed Tll -a, T11 -b, and Tll -c, were randomly selected and extensively characterized .
Indirect Immunofuorescence Assays. Phenotypic analyses were performed using indirect immunofluorescence assays with a fluorescein-conjugated goat anti-mouse IgG (Meloy Laboratories Inc., Springfield, VA) second antibody. 104 cells were analyzed in each sample and results were expressed as histograms displaying number of cells vs. fluorescence intensity on a log scale . Antibodies used in the study were anti-T3 (RW28C8, Leu-4), anti-Ti (9H5, directed against a clonotypic determinant present on Jurkat), antiTII1 (3Pt2H9), anti-T112 (lold241C), and ant-T113 (lmono2A6). An irrelevant ascites (1HT4-4E5) was used as a control of fluorescence background . Antibodies were used at saturating dilutions in the assay (1 :200 final dilution) .
Immunoprecipitations . 2 x 10' cells were surface labeled with 125 1 (IMS30, Amersham Corp., Arlington Heights, IL) for 15 min at room temperature using a standard lactoperoxidase method . Labeled cells were washed and cell lysates were prepared by resuspending the cell pellet in 400 pl of radioimmunoprecipitation assay (RIPA) buffer containing 1% Triton X-100, 0.15 M NaCl, 0.01 M NaH2PO4, 1 mM EDTA, 1 mM EGTA, 1 mM Naf, and protease inhibitors, and by agitating for 40 min at 4°C. Celllysates were then extensively precleared with formalin-fixed Staphylococcus aureus bacteria and protein A-Sepharose 4B beads (Pharmacia Fine Chemicals) bound to a nonreactive antibody (anti-T8) . Aliquots of precleared lysates were subsequently incubated with specific antibody (either antiT3 or anti-T11 1 antibodies) coated protein A-Sepharose beads for 6 h at 4°C. Immune precipitates were washed four times with RIPA buffer and submitted to SDS-PAGE analysis after treatment with 5% 2-ME (reducing conditions). Gels were dried and radiolabeled precipitates were visualized by autoradiography after 3 d of exposure.
Binding Assays . Purified anti-T111 antibody (3Pt2H9) was labeled with 10 ul of immobilized lactoperoxidase/glucose oxidase (Enzymobeads; Bio-Rad Laboratories, Richmond, CA) in 40 mM sodium phosphate, pH 7.2, 0.4% glucose, and 1 MCi 1251 for 5 min and separated over a 1 ml Biogel P-6 column (Bio-Rad Laboratories) . 0.1-6 x 106 cpm labeled antibody (sp act 104 cpm/pmol) was added to 106 cells overlayed onto 0.2 ml of a 1.5:1 mixture of dibutyl phthalate :dioctyl phthalate (Aldrich Chemical Co., Milwaukee, WI). After 30 min at 4°C, tubes were centrifuged (8,500 g for 1 min), the tips of the tubes containing the cell pellets were cut, and the cell bound and free radioactivity was determined in a gamma counter. Nonspecific binding ofthe antibody was evaluated by performing the experiment in the pres-ence of an excess ofcold antibody (ascites used at a 1 :50 dilution) and was subtracted from total binding, with specific binding representing 95% of total binding .
Northern Blot Analysis. Total RNA was extracted from 10' cells using the VRC method (Vanadyl Ribonucleoside Complex, New England Biolabs, Beverly, MA) . 20-25 Rg ofRNA per lane were run over a 1.3% agarose gel and blotted onto a Gene Screen Plus nylon (New England Nuclear, Boston, MA) membrane. Prehybridized filters were hybridized with a PBl (Barn HI fragment) probe (16) labeled with 32P using the random priming method to a sp act of 108 cpm/pg DNA. Filters were washed at 65°C with 2x SSC 0.5% SDS, then 0.5x SSC 0.5% SDS, and exposed for 18-36 h with intensifying screen (DuPont Co., Wilmington, DE) . The positions of28S and 18S RNA are given as a reference. For HC21 gene expression (H. C . Chang and E. L. Reinherz, submitted for publication), cells were stimulated either with antiT3, antiT112 and antiT113 antibodies, or .calcium ionophore in the presence of PMA (5 ng/ml final concentration), before extracting the RNA . Northern blots were hybridized with the 640-bp HC21-h probe and washed as above .
Analysis of Phosphatidyl Inositol Turnover. Inositol metabolites were analyzed as previously described (17) . Briefly, 107 cells were incubated in 1 ml of Hepes-buffered (pH 7.4) Hank's solution supplemented with 0.5% gelatin and 40 pCi of [3H]myo inositol (New England Nuclear) for 3 h at 37°C. Cells were diluted 10-fold in RPMI 1640 medium containing 10 1Y0 FCS and incubated overnight at 37°C, then washed and resuspended in 2 ml of 10% FCS, 10 mM Hepes buffer, pH 7.4, RPMI 1640 containing 10 mM LiCl (to inhibit the metabolism of inositol phosphates to inositol) . Cells were then triggered either with ascites (used at a 1 :200 final concentration) antiT3 (2Ad2A2), antiTi, anti-T112 and anti-T11 3, or antiT11 1 antibody (3Pt2H9, shown to bind to the CD2 molecule without inducing activation) (4) . After a 10-min incubation at 37°C, cells were rapidly pelleted and lysed with 0.75 ml of chloroform/methanol/HCI (at a ratio of 100:200:2) before extraction ofthe inositol phosphates and separation over a Dowex column (Sigma Chemical Co., St. Louis, MO) (17) . Inositol phosphates IP,, IP2, and IP3 were eluted together with 2 M ammonium formate, 0.1 M formic acid solution . Fractions of0.4 ml were collected and counted in the presence ofaquasol (New England Nuclear).
Determination of Cytosolic Cat* . Cells were loaded with 2 pg/ml of the acetoxymethylester of indo-1 (Molecular Probes, Junction City, OR) in RPMI 1640 plus 2% FCS for 45 min at 37°C, and diluted fivefold in the same medium before running on an Epics V flow cytometer using an ultraviolet laser illumination (40 mW at 351-364 nm) provided by an argon ion laser (Innova 90-5; Coherent Laser Products, Palo Alto, CA) . After Cat* binding, the indo-1 dye exhibits changes in fluorescence emission wavelengths from 480 to 410 nm (18) . The ratio of 410 :480 nm indo-1 fluorescence was recorded vs. time. The short wavelength fluorescence was detected through a 410-nm bandpass filter after being reflected by a blue reflective dichroid, and the longer wavelength fluorescence was detected through a 480-nm bandpass filter after passing through the same dichroic. Fluorescence ratio determination allows measurements of Cat* increase independent of variability of intracellular dye concentration. Samples were analyzed at room temperature by running the indo-l-loaded cells for 1 min to determine the baseline, then adding stimulating antibodies: antiT3 (2Ad2A2, IgM), antiTi (IgG2) at a 1 :100 final dilution, or antiT112 and antiT113 (IgG2 and IgG3, respectively) at a 1 :100 final dilution. In some experiments, the calcium ionophore A23187 (Sigma Chemical Co.) was added at a 1 pg/ml final concentration as a positive control. Samples were analyzed for 6 min and results are expressed as Cat* increase in ordinate (fluorescence ratio is given in arbitrary units) vs. time in min (abscissa) . One arbitrary unit represents -200 nM of Cat* rise (as evaluated in quantitative parallel experiments using the quin-2 fluorescent dye).
IL-2 Production Assay. Evaluation ofIL-2 production was assayed as previously described by Marrack et al. (19) . 5 x 10" cells were plated in 96-well round-bottomed plates (final volume, 0.2 ml) and incubated at 37°C with anti-T3 (2Ad2A2), anti-Ti at a 1 :200 final dilution or antiT112 and antiT113 antibodies at a 1 :100 final dilution in the presence of 5 ng/ml of PMA (Sigma Chemical Co.). Supernatants were harvested after 24 h and titrated in duplicate in serial twofold dilutions (ranging from 1 :4 to 1 :4,096) for their ability to support the growth ofthe IL-2-dependent cell line CTLL20 . The highest dilution ofculture supernatant able to maintain 5 x 103 CTLL20 viable cells (as evaluated in a trypan blue exclusion assay) was said to contain 1 U of IL-2. Results were expressed as arbitrary U/ml IL-2 secreted. We estimate one arbitrary unit to be equivalent to 0.25 U of rIL-2 from Biogen (Cambridge, MA).
Cell Transfection. For reconstitution of CD2 expression on T11 -mutants, the full-length Tll cDNA (clone PB2) (16) was inserted into the Bam HI site of the pPink-2 vector (kindly provided by Dr. P Ohashi, Toronto, Canada), in which expression of the cDNA insert is under the control of the spleen focus-forming virus long terminal repeat (LTR), while the presence ofthe neomycin gene provides a selection marker for the antibiotic G418. Such generated plasmids were grown in Escherichia coli strain HB101 and amplified in the presence of chloramphenicol . Culture was converted to protoplasts and fused to the Tll -c cells in the presence of 40% polyethylene glycol 1500 as previously described (15) . After 48 h, cells were plated at 30,000 cells/well in 96-well flat-bottomed microtiter plates in the presence of2 mg/ml geneticin G418 (Gibco Laboratories, Grand Island, NY) . Resistant clones were selected for CD2 expression using an indirect immunofluorescence assay, and cells were maintained in culture in the presence of 0.5 mg/ml G418.
Results
Selection of CD3Ti+ CD2 -Variants of the J77 Cell Line. Variants of the jurkat cell line, clone J77-6.8 lacking the CD2 molecule, were obtained by mutagenesis, immunoselection, and cell sorting (see Materials and Methods). CD2 -colonies were screened by indirect immunofluorescence : 19 clones displaying the CD3 Ti+ CD2 -phenotype were obtained and three of these clones, termed Tll -a, Tll -b, and Tll -c, were randomly selected and used for further characterization. The phenotype of one of these CD2 -variants (T11 -b) is shown in Fig . 1 . Antibodies directed to different epitopes of the CD2 molecule failed to react with the T11 -variants, while all three of these epitopes were found to be expressed on the J77 parental cell line. Furthermore, CD3 and Ti expression as judged by peak mean channel fluorescence intensity was clearly comparable onJ77 and Tll -clones, suggesting the presence of a similar number of TCR complexes with no discernable requirement for CD2 protein in CD3 Ti surface expression. An identical set of reactivities was observed for clones Tll -a and T11 -c (not shown). Phenotypic analysis ofJ77 and CD2 -cell lines. Reactivity ofdifferent mAbs with J77 and CD2 -variant cells was assayed by indirect immunofluorescence using cytofluorimetric analysis . 104 cells were run per sample and the diagrams represent the number of cells (ordinate) vs . intensity offluorescence expressed in a logarithmic scale (abscissa) . Reactivity of the different antibodies (thick line) is compared withbackground offluorescence obtained with an irrelevant antibody (thin line).
CD2 Molecules Are Undetectable on the Surface of CD2-Variants. As an alternative approach for the identification of CD2 molecules, immunoprecipitation experiments were performed on the J77 parental line, and on T11 -a and T11 -c clones . To this end, lysates from surface-labeled cells were immunoprecipitated either with purified anti T11 i or anti T3 antibody linked to protein A-Sepharose beads and immunoprecipitates washed and analyzed by SDS-PAGE . As shown in Fig. 2 a, anti-T111 immunoprecipitates a 50-kD protein from J77 (lane C) . In contrast, even overexposure of the autoradiogram failed to reveal any corresponding band from T11 -cells (lanes A and B) . Anti-T3 antibody precipitates the CD3 subunits on the three cell lines (lanes D-F) that appear as two bands of -27 and N21-kD from theJurkat cell line . Parallel immunoprecipitation conducted with the antiTi antibody on T11 -variants and 177 cells established that a Ti molecule with similar biochemical characteristics was also present on these cells (our unpublished data).
As a more quantitative means of assessing numbers of CD2 molecules on theJurkat variants, a radioisotope binding assay was developed using 125 1-labeled anti-T11 1 antibody. As shown in Fig. 2 b, a high and saturable specific binding was observed on J77 cells. Scatchard analysis of the data indicated the presence of "14,000 sites per cell (not shown). By contrast, no specific binding was detected on T11 -c. Similar data was observed with T11 -a and T11 -b clones . Given the sensitivity of this binding method, we estimate that the T11 -mutants must express < 100 Tll molecules on their cell surface. Using an identical methodology with 125 1-labeled anti-T3 and anti-Ti antibodies, we determined that J77 and T11 -c each expressed "10,000 copies of TCRs. Thus, the level of CD3Ti expression is not dependent upon CD2 expression .
Analysis o,f CD2 Gene Expression in CD2-Variants. To identify whether the loss of CD2 surface expression was due to a pretranslational effect, blot analysis was performed with RNA isolated from the T11 -a, T11 -b, and T11 -c cells. 25 ttg of total RNA was run on a 1.3% agarose gel, transferred to Gene Screen Plus membrane, and probed with the 32 p-labeled T11/cDNA, PBl . As shown in Fig. 3 , hybridization with the PB1 probe revealed two transcripts of 1 .7 and 1.3 kb specifically in the T cell line J77 (lane A) . In contrast, the CD2 transcripts were not detectable in the B cell line Laz 509 (lane E) . Although some level of CD2 gene transcription was detected in all three T11 -mutants (lanes B, C, and D), this was substantially reduced in comparison with the parental cell line (up to 20-fold reduction) . Note that the 1 .7-kb transcript predominates in the T11 -a and T11 -b clones, whereas the 1.3-kb transcript predominates in the T11 -c clone. Given the fact that either form of CD2 message can give rise to functional CD2 protein, we cannot exclude an extremely low translational level in these mutant cells. Presumably, the irradiation-induced mutagenesis has resulted in a defect in the regulatory region of the CD2 gene or another cis-or trans-acting regulatory element affecting CD2 transcription. The possibility that irradiation has introduced a point mutation in the CD2 sequence that affects message stability or translatability also cannot be ruled out.
Phosphatidyl Inositol Turnover. To characterize the status of early membrane signaling events in these T11 -mutants, induction of PI turnover was evaluated after stimulation via CD2 or C133 -Ti. To this end, J77 and T11 -a and T11 -c cells were labeled with [3H]inositol and stimulated with anti-T3, anti-Ti, or a combination of anti T112 and anti T113 antibodies . As a negative control, clones were stimulated with an antibody directed against a nonmitogenic epitope, antiTll.t (4). Results from a representative experiment are shown in Table I . As indicated, anti-T112 and anti-T113 dramatically increase PI turnover in J77; a 6.3-fold increase of inositol phosphates was found in comparison with stimulation with the control anti-T11 1 antibody. In contrast, these antibodies were ineffective in stimulating T11 -a and T11 -c cells, thereby demonstrating the functional lack of CD2 structures on these mutants. However, when antiT3 was used to stimulate the T cell populations, a 4.1-, 3.5-, and 4.1-fold increase in PI turnover was found for J77, T11 -a, and T11 -c cells, respectively. AntiTi antibody, like anti-T3, was able to induce phosphatidyl inositol breakdown in all three cell lines, although the level of activation was found to be less than that with anti-T3 (a 1.7, 1.6, and 1.2 increase was found, respectively) . Thus, PI turnover mediated via the CD3Ti pathway occurs in the absence of detectable CD2 surface structures .
Cytosolic Ca" Measurement. To examine alteration in [Ca2+ ]i after CD3Ti or CD2 stimulation, cells were loaded with the fluorescent dye indo-1 and triggered with specific antibodies (Fig . 4) . As previously reported (15, 20) , incubation ofJ77 F, respectively) , strongly indicating that detectable surface CD2 expression is not required for HC21 induction.
IL-2 Production. IL-2 production and secretion by CD2 + and CD2 -Jurkat populations was evaluated after stimulation as described in Materials and Methods. As shown in a representative experiment (Table II) , supernatants of cells incubated with PMA alone contain only low levels of IL-2 (48 U/ml). Addition of anti T112 and anti-T113 antibodies inducesJ77 cells to produce high levels of IL-2 (up to 2,048 U/ml), but is without any effect on CD2-mutants. Anti-T3 or antiTi antibody stimulation leads to significant IL-2 production in all tested cell lines (128-256 U/ml). It should be noted that since serial twofold dilutions were used in the assay, we assume that results obtained by CD3Ti stimulation and expressed in Table II do not represent any quantitative difference between J77 and T11 -clones . Thus, surface CD2 expression is not required for IL-2 production after CD3Ti stimulation ofJurkatderived cells.
Reconstitution of Surface CD2 Expression on the T11 -c Clone. The above studies indicated that the T11 -mutants could not be triggered to undergo early biochemical activation events upon stimulation with anti-T112 and anti-T113 antibodies . To prove whether this defect was a direct consequence of the absence of the CD2 gene product, we performed reconstitution analysis . To this end, a full-length cDNA clone (PB2 ; reference 16) was transfected into Tll -c cells using a previously described protoplast fusion method (15) . After G418 selection and immunofluorescence screening, CD2 + clones were identified . Fig. 6 (left panel) represents the immunofluorescence analysis of one reconstituted T11 -c clone, termed T11 -cR, which clearly expresses both CD3 and CD2 molecules. Note that the level of CD2 expression in T11 -cR cells is less than that of the parental Jurkat cell line, but clearly detectable unlike the Tll -mutants (Fig . 1) . Stimulation of T11 -cR by anti-T11 2 and anti-T113 antibodies induced a readily detectable rise in [Ca2 + ]; in a substantial number of cells (Fig . 6, right  panel) . As expected, reconstitution of surface CD2 expression did not alter the capacity to stimulate cells via CD3Ti molecules since both T11 -c and T11 -cR cell lines were found equally triggerable through their TCRs (data not shown) . Discussion CD2-mutants have been derived and characterized from the CD2+CD3Ti+ Jurkat human T cell line . Surface expression of the CD2 molecule was undetectable using a series of mAbs directed at three different epitopes of the CD2 structure (T111, T112, T113) and any of three separate assays : indirect immunofluorescence, Ti + PMA   J77  <4  2,048  128  256  T11 -a  <4  <4  128  128  Tl l -b  <4  <4  256  256  T11 -c  8  8 128 128 immunoprecipitation-SDS-PAGE, and radiolabeled antibody binding. Furthermore, the T11 -a, T11 -b, and T11 -c clones were incapable of being activated by a combination of antiT112 and anti T113 antibodies, which are extremely potent in stimulating the parentalJurkat clone and resting peripheral T lymphocytes (4). Thus, measurement of alterations of [Ca2+]i, HC21 gene induction and IL-2 production, all sensitive assays of T lymphocyte activation, gave no evidence for stimulation of T11 -mutants via the CD2 structure. It should be noted that complete absence of CD2 structures cannot be formally excluded in the three T11 -variants characterized herein given that a low level of CD2 gene transcription was detected in each mutant population . However, according to the sensitivity of the radiolabeled binding assay, these T11 -clones express, at most, <100 molecules/cell. This corresponds to at least a 140-fold reduction in the number of surface CD2 in comparison with the parental Jurkat line.
The basis for the defect in CD2 expression in T11 -variants is presently unknown. Noteworthy, at the level of RNA expression is the clear predominance of either the 1.7-or 1.3-kb message in mutant cell lines. These results raise the possibility that the mutation occurs either within a regulatory region of the CD2 gene or as-and/or trans-activating elements important for CD2 expression . Moreover, since transfection of such T11 -mutants with human CD2 cDNA driven by an exogenous LTR results in a high level of transcription (data not shown) with surface expression of CD2 less than the parental Jurkat cell line (compare Fig. 6 , left panel with Fig. 1) , it is possible that additional defects at the post-transcriptional level (e .g ., defect in a transport system of the molecule to the membrane) could lead to lack of normal surface CD2 protein expression . However, such C132-reconstituted cells can clearly be triggered via the CD2 molecule to augment [Ca 2+ ]i as expected .
One unequivocal finding of the present study is the observation that CD3 and Ti molecules are found on the surface of CD2 -mutants and that CD2 expression apparently has no effect on CD3Ti expression since the number of molecules of CD3Ti on Jurkat vs . CD2-variants were quantitatively similar as judged by binding assay. Perhaps more importantly, these same experiments demonstrate that CD2 -mutants can be triggered through their CD3Ti components to mediate phos-phoinositol turnover, a rise in [Ca2 + ]i, nuclear activation (including HC21 activation), and IL-2 gene transcription, translation, and secretion. Thus, in theseJurkat variants, the CD3Ti-a/S receptor does not require CD2 for functional activation . We observed in the present study that stimulation of the CD3Ti structure with antiTi antibody was less effective than with anti-CD3 antibody at inducing early biochemical events, including phosphatidyl inositol turnover and [Ca 21 ]; rise . In contrast, both antiTi and anti-CD3 antibodies induced similar levels of IL-2 production . This result is perhaps not surprising since it is generally assumed that the CD3 subunits are involved in signal transduction or, at the least, linked more proximal to transduction elements than the antigen/MHC binding heterodimer. That IL-2 production is equivalent after stimulation of the CD3Ti complex via clonotypic vs . monomorphic structures is perhaps also not unexpected if only a critical threshold alteration in phosphoinositide turnover or [Ca2+ ] ; is required for IL-2 gene induction.
Nevertheless, we cannot exclude the possibility that the avidity, isotype subclass, or other intrinsic properties of the anti-CD3 and anti Ti antibodies used in these studies (e.g., the anti-CD3 is IgM while the anti-Ti is IgG2) are themselves responsible for the differences in the early biochemical activation events .
The relative CD2 independence of the TCR complex demonstrated herein by genetic manipulation contrasts with the conclusion of certain other functional studies (21, 22) . The latter have suggested that perturbation of the CD2 molecule with mAbs affects subsequent stimulation through CD3Ti. Whether this is a direct effect of CD2 in regulating activation through CD3Ti is controversial since other reports show that modulation of CD2 molecules has no effect on early metabolic activation events observed after CD3Ti triggering, including inositol breakdown and alterations in [Ca2+ ]; (23) . Given that modulation experiments require preincubation of T cells for prolonged periods of time with mAbs, indirect immunoregulatory effects cannot be excluded . The present genetic approach described herein, therefore, firmly argues for the C132-independent nature of certain TCR triggering events in Jurkat and presumably other activated T cell populations.
A CD3 + IL-2-dependent clone lacking expression of CD2 on the membrane has recently been derived from peripheral blood of a healthy subject (24) . This clone was found to express components of the "second type" TCRy/S complex while CD2 was undetected by indirect immunofluorescence techniques. These CD2 -cells were still able to be induced to proliferate and display cytotoxic activity after triggering with antibodies directed against either CD3 or Ti y protein. Although no quantitative binding analysis was performed to rule out detectable CD2 surface protein expression by a more sensitive technique, these results establish that the physical presence of normal numbers of CD2 molecules on the membrane of this cell type is also not an absolute requirement for subsequent expression and function of its TCR (24) .
The above results are in marked contrast to the unequivocal evidence indicating that CD3Ti expression is necessary for activation of mature T lymphocytes through their CD2 structure (4, 15, 25, 26) . In this regard, we recently described CD3 -Ti -CD2+ mutants of the Jurkat line that failed to express a 1.3-kb Ti R gene transcript (15) . These mutants were unable to be stimulated by either CD3Ti or CD2 pathway to increase phosphoinositide turnover, mobilize calcium, or induce the IL-2 gene . However, after reconstitution via transfection with a Ti R cDNA driven by an exogenous LTR, CD3Ti expression was restored as well as the activation capacity through the CD2 and CD3Ti structures (15) . Collectively, the above results suggest that while Lion of T cells via boned that these one CD3-Ti-'y/8 3-Ti is necessary for activareciprocal is not true. Nevertheless, it has to be cauns have been made on CM-Ti-a/ß jurkat clones and clone, both of which represent cycling cell populations. It remains to be demonstrated whether T cell activation can proceed from the Go state of cells whose CD2 structure is absent or made nonfunctional. In thi regard, it is a likely possibility that transduction of signaling via CD2 affects st lation through the CD3-Ti complex. Compelling functional data has already been provided to suggest that both pathways cooperate in a synergistic fashion to induce T cell proliferation. Thus, a combination of submitogenic anti-CD3 and anti Tll antibodies together lead to T cell proliferation (27) . The ability ofCD2 to augment ce oflow concentrations of antigenic stimuli that might be encountered during natural immune perturbations could be ofsubstantial physiologic significance. Furthermore, the CD2 molecule appears to have an important role in T lymphocyte adhesion by facilitating the binding of regulatory and effector T cells to their cognate partners through direct interaction with the ubiquitous surface structure LFA-3 (5). Since binding of CD2 to LFA-3 leads to at least one of the signals required for T cell stimulation via C132, a physiologic role for this pathway Bested in both the mature peripheral T cell compartment (6, 7) and the immature thymus compartment (28, 29) . In this context, the role of C132 in regulating activation ofT lineage cells at different stages ofontogeny, particularly those undergoing cell cycle entrance, remains to be fully elucidated. Summary 0 investigate the requirement W CD2 expression in activation ofT lymphocy , the CD3-Ti antigen/MHC receptor complex, we produced and characterized a series of CD2-Jurkat variants . These mutants lack detectable surface CD2 as determined by indirect immunofluorescence, immunoprecipitation analysis, and specific radiolabeled antibody binding assay, but nevertheless, expressed normal numbers ofCD3-Ti receptors. As expected, the combination ofanti-CD2 antibodies, termed anti-T112 and anti -T113, which are mitogenic for resting T lymphocytes, failed to stimulate activation of these variants . In contrast, triggering of their CD3-Ti components resulted in the normal set of T lymphocyte-associated activation including phosphoinositide turnover, elevation in intracellular free calcium, early gene-induction events, and IL-2 production . Assuming that the jurkat cell line is representative of normal cycling human T lymphocytes, we conclude that the presence ofthe CD2 molecule on the plasma membrane is not in itself a requirement for an operational CM-Ti-a/ß receptor.
